LIANTONIO, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 8.882
AS - Asia 3.340
EU - Europa 2.623
SA - Sud America 856
Continente sconosciuto - Info sul continente non disponibili 401
AF - Africa 129
OC - Oceania 7
Totale 16.238
Nazione #
US - Stati Uniti d'America 8.595
SG - Singapore 1.382
IT - Italia 920
CN - Cina 753
BR - Brasile 691
HK - Hong Kong 411
SE - Svezia 291
RU - Federazione Russa 273
DE - Germania 234
VN - Vietnam 218
FR - Francia 214
FI - Finlandia 175
UA - Ucraina 168
GB - Regno Unito 149
CA - Canada 123
BD - Bangladesh 117
IN - India 103
ID - Indonesia 65
AR - Argentina 51
BE - Belgio 39
TR - Turchia 37
MX - Messico 34
ZA - Sudafrica 34
IQ - Iraq 32
NL - Olanda 31
EC - Ecuador 27
PK - Pakistan 25
SA - Arabia Saudita 25
JP - Giappone 24
CR - Costa Rica 23
CO - Colombia 22
VE - Venezuela 22
CI - Costa d'Avorio 21
PL - Polonia 21
TT - Trinidad e Tobago 20
UZ - Uzbekistan 18
CL - Cile 17
ES - Italia 17
CZ - Repubblica Ceca 16
IL - Israele 16
MA - Marocco 15
HN - Honduras 14
LT - Lituania 14
IE - Irlanda 13
MY - Malesia 12
NI - Nicaragua 12
PH - Filippine 12
SV - El Salvador 12
GP - Guadalupe 11
GT - Guatemala 10
IR - Iran 10
NP - Nepal 10
PR - Porto Rico 10
PY - Paraguay 10
TN - Tunisia 10
EG - Egitto 9
KE - Kenya 9
AE - Emirati Arabi Uniti 7
AT - Austria 7
KR - Corea 7
PE - Perù 7
SC - Seychelles 7
AU - Australia 6
ET - Etiopia 6
JO - Giordania 6
KZ - Kazakistan 6
PA - Panama 6
PS - Palestinian Territory 6
TW - Taiwan 6
DZ - Algeria 5
JM - Giamaica 5
KG - Kirghizistan 5
TH - Thailandia 5
UY - Uruguay 5
AL - Albania 4
BO - Bolivia 4
CH - Svizzera 4
DK - Danimarca 4
OM - Oman 4
RO - Romania 4
AM - Armenia 3
BB - Barbados 3
CW - ???statistics.table.value.countryCode.CW??? 3
EE - Estonia 3
GE - Georgia 3
LB - Libano 3
LV - Lettonia 3
MD - Moldavia 3
RS - Serbia 3
SN - Senegal 3
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
DM - Dominica 2
HU - Ungheria 2
NG - Nigeria 2
SY - Repubblica araba siriana 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
Totale 15.821
Città #
Ashburn 975
Singapore 771
Fairfield 739
San Jose 605
Woodbridge 567
Chandler 439
Hong Kong 409
Houston 395
Jacksonville 382
Cambridge 316
Milan 306
Dallas 295
Seattle 295
Nyköping 247
Wilmington 241
Ann Arbor 235
Beijing 199
Council Bluffs 197
Bari 124
Lauterbourg 119
New York 118
Los Angeles 117
Lawrence 105
Rome 104
Roxbury 103
Nanjing 89
Santa Clara 86
Princeton 82
Boardman 80
São Paulo 71
Ho Chi Minh City 67
Des Moines 65
Helsinki 62
Inglewood 60
Jakarta 44
Hanoi 43
Buffalo 41
Columbus 39
Munich 39
Brussels 38
Jiaxing 36
San Diego 36
Chicago 35
Toronto 33
Nanchang 32
Falkenstein 29
Brooklyn 28
Dong Ket 27
Hebei 27
Shenyang 27
Montreal 26
London 25
Frankfurt am Main 22
Phoenix 22
Rio de Janeiro 22
Tokyo 22
Abidjan 21
Brasília 21
Falls Church 21
The Dalles 21
Turku 21
Moscow 20
Nuremberg 20
Atlanta 19
Johannesburg 19
San José 19
Warsaw 18
Dearborn 17
Denver 17
Shanghai 17
Washington 17
Belo Horizonte 16
Changsha 16
Guangzhou 16
North Bergen 16
Orem 16
Paris 16
Brno 15
Tashkent 15
Baghdad 14
Dhaka 14
Mexico City 14
Pune 14
Chennai 13
Biên Hòa 12
Dublin 12
Jeddah 12
Naples 12
San Mateo 12
Turin 12
Figino 11
Haiphong 11
Managua 11
Manchester 11
Taranto 11
Tianjin 11
Augusta 10
Boston 10
Guayaquil 10
San Francisco 10
Totale 10.419
Nome #
Effects of Nandrolone in the counteraction of skeletal muscle atrophy in a mouse model of muscle disuse: molecular biology and functional evaluation 258
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force 242
Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin 222
Antioxidant treatment of hindlimb-unloaded mouse counteracts fiber type transition but not atrophy of disused muscles 216
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 212
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 211
On the metabolically active form of metaglidasen: improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal muscles 211
Elucidating the Contribution of Skeletal Muscle Ion Channels to Amyotrophic Lateral Sclerosis in search of new therapeutic options 210
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. 204
Ion channels in drug discovery and safety pharmacology 196
Activation and inhibition of kidney CLC-K chloride channels by fenamates 195
Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine 195
Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse 178
A multidisciplinary evaluation of the effectiveness of cyclosporine A in dystrophic mdx mice 165
Carboxylic acids and skeletal muscle chloride channel conductance: Effects on the biological activity induced by the introduction of an aryloxyalkyl group α to the carboxylic function of 4-chloro-phenoxyacetic acid 164
Alteration of stim1/orai1-mediated soce in skeletal muscle: Impact in genetic muscle diseases and beyond 160
Paracrine Effects of IGF-1 Overexpression on the Functional Decline Due to Skeletal Muscle Disuse: Molecular and Functional Evaluation in Hindlimb Unloaded MLC/mIgf-1 Transgenic Mice 155
Effect of rat hindlimb suspension on cable properties, ionic conductances and fiber type composition of slow-twitch muscle. 153
Pre-clinical trials in Duchenne dystrophy: what animal models can tell us about potential drug effectiveness 153
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies 152
Structural requisites of 2-(p-chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC-1 149
Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1 148
Pharmacovigilance database search discloses ClC-K channels as a novel target of the AT1 receptor blockers valsartan and olmesartan 148
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disorders 148
Calcium homeostasis is altered in skeletal muscle of spontaneously hypertensive rats cytofluorimetric and gene expression analysis 147
Pharmacological characterization of chloride channels belonging to the ClC family by the use of chiral clofibric acid derivatives 146
Fiber type-related changes in rat skeletal muscle calcium homeostasis during aging and restoration by growth hormone 146
Phosphorylation and IGF-1-mediated dephosphorylation pathways control the activity and the pharmacological properties of skeletal muscle chloride channels 145
Statins and fenofibrate affect skeletal muscle chloride conductance in rats by different impairing ClC-1 channel regulation and expression 143
Therapeutic approaches to genetic ion channelopathies and perspectives in drug discovery 143
Antioxidant treatment of hindlimb-unloaded mouse in vivo counteracts fiber type transition but not atrophy of disused skeletal muscles 142
Protein kinase C theta (PKCθ) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: a biophysical and gene expression study in mouse models lacking the PKCθ 138
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 138
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 136
New potent mexiletine and tocainide analogues evaluated in vivo and in vitro as antimyotonic agents on the myotonic ADR mouse 135
Peptidic and Nonpeptidic Growth Hormone Secretagogues exert a protective effect on mitochondrial parameters analysed in a rat model of cachexia 135
Effect of HMG-CoA reductase inhibitors on excitation-contraction coupling of rat skeletal muscle 134
A novel kcna2 variant in a patient with non-progressive congenital ataxia and epilepsy: Functional characterization and sensitivity to 4-aminopyridine 134
Recovery of the soleus muscle after short- and long-term disuse induced by hindlimb unloading: effects on the electrical properties and myosin heavy chain profile 133
Age-dependent effects of disuse on electrophysiogical parameters and calcium homeostasis in the soleus muscle of hindlimb-unloaded mice 133
Identification of sites responsible for the potentiating effect of niflumic acid on ClC-Ka kidney chloride channels 132
The alteration of calcium homeostasis in adult dystrophic mdx muscle fibers is worsened by a chronic exercise in vivo 131
Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium 131
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 130
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 129
Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms. 129
In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats: A new drug target for hypertension? 129
Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle 128
Functional Study of Novel Bartter's Syndrome Mutations in ClC-Kb and Rescue by the Accessory Subunit Barttin Toward Personalized Medicine 127
Taurine and skeletal muscle disorders 125
Molecular determinants of 2(p-chlorophenoxy)propionic acid for modulation of the native chloride channel conductance of rat skeletal muscle 124
Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity 124
Taurine and skeletal muscle ion channels 123
Kv1.1 channelopathies: Pathophysiological mechanisms and therapeutic approaches 122
An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 120
Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions 119
Block of renal CLC-K channels by phenoxy-alkyl derivatives of clofibric acid 117
Therapeutic Approaches to Tuberous Sclerosis Complex: From Available Therapies to Promising Drug Targets 116
The Biallelic Inheritance of Two Novel SCN1A Variants Results in Developmental and Epileptic Encephalopathy Responsive to Levetiracetam 116
Mechanisms of block of muscle type CLC chloride channels 116
Comparison of excitability parameters and sodium channel behavior of fast- and slow-twitch rat skeletal muscles for the study of the effects of hindlimb suspension, a model of hypogravity. 114
Involvement of Barttin Subunit in Pharmacological Potentiation of CLC-K Channels Expressed in Xenopus Oocytes 114
Protein Kinase C-Theta Controls the CLC-1 Chloride Channel Function and Skeletal Muscle Phenotype: A Biophysical and Gene Expression Study in Pkc-Theta Null Mice 114
Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia 113
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/non-peptidyl structure 113
Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome 112
Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockers 112
Potential targets for skeletal muscle impairment by hypogravity: basic characterization of resting ionic conductances and mechanical threshold of rat fast- and slow-twitch muscle fibers 112
Pharmacology of CLC chloride channels and transporters 111
Molecular determinants of differential pore blocking of kidney CLC-K chloride channels 110
VARIOUS MEMBERS OF CLC FAMILY ARE DIFFERENTLY AFFECTED BY NEWLY SYNTHESIZED CLOFIBRIC ACID DERIVATIVES. 110
I-J loop involvement in the pharmacological profile of CLC-K channels expressed in Xenopus oocytes 109
An olive oil–derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function 109
Disuse of rat muscle in vivo reduces protein kinase C activity controlling the sarcolemma chloride conductance 108
Investigating a Benzofurane Derivative Binding Site on Human CLC-5 107
Potential benefits of taurine in the prevention of skeletal muscle impairment induced by disuse in the hindlimb-unloaded rat 107
Therapeutic approaches to ion channel diseases 106
Paving the way for Bartter syndrome type 3 drug discovery: a hope from basic research 106
Targeting kidney CLC-K channels: pharmacological profile in a human cell line versus Xenopus oocytes 105
Taurine and skeletal muscle ion channels 105
null 100
Potent and stereoselective use-dependent block of skeletal muscle Na+ channels by a new proline-like tocainide derivative 99
Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid 98
Mechanism of Interaction of Niflumic Acid with Heterologously Expressed Kidney CLC-K Chloride Channels 96
Sarcoplasmic Reticulum Ca2+ Buffer Proteins: A Focus on the Yet-To-Be-Explored Role of Sarcalumenin in Skeletal Muscle Health and Disease 94
Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis 94
Independent impairment of chloride channel function and calcium homeostasis in dystrophic muscle of exercised MDX mouse 93
null 93
Brugada Syndrome: More than a Monogenic Channelopathy 92
Molecular switch for CLC-K Cl– channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands 92
Mechanism of block of single protopores of the Torpedo chloride channel ClC-0 by 2-(p-chlorophenoxy)butyric acid (CPB) 92
Effects of sacubitril-valsartan on aging-related cardiac dysfunction 91
Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications 91
Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle 91
Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: Outcome of a large array of in vivo and ex vivo tests 91
null 90
Taurine ameliorates in vitro and in vivo the electrical and contractile properties of skeletal muscle fibres of dystrophic mdx mouse 90
Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase. 89
Potent effect of chiral derivative of mexiletine on rat skeletal muscle sodium channel 89
null 87
Totale 13.210
Categoria #
all - tutte 66.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.790


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022640 0 0 0 0 42 63 48 37 56 57 131 206
2022/20231.252 200 113 93 91 125 186 13 147 192 17 36 39
2023/2024494 31 79 26 64 50 106 24 20 5 36 7 46
2024/20252.293 81 37 153 75 77 225 226 216 89 123 301 690
2025/20265.163 655 252 457 495 549 243 614 149 572 480 197 500
2026/20271.846 176 274 433 868 95 0 0 0 0 0 0 0
Totale 16.238